Highline Wealth Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44K Sell
11
-22
-67% -$3.29K ﹤0.01% 1294
2026
Q2
$5.02K Buy
33
+31
+1,550% +$5.16K ﹤0.01% 862
2026
Q1
$420 Hold
2
– – ﹤0.01% 1248
2025
Q4
$568 Hold
2
– – ﹤0.01% 968
2025
Q3
$617 Sell
2
-1
-33% -$313 ﹤0.01% 978
2025
Q2
$943 Buy
3
+1
+50% +$289 ﹤0.01% 730
2025
Q1
$525 Buy
+2
New +$541 ﹤0.01% 840

Other funds holding PODD

Highline Wealth Partners's PODD Position: Q3 2026 in Review

Highline Wealth Partners reduced its Insulet (PODD) stake by 67% in Q3 2026, selling an estimated $3.29K and leaving 11 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Highline Wealth Partners first reported a position in PODD in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.02K in Q2 2026. 129 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Highline Wealth Partners held 11 shares of Insulet worth $1.44K as of Q3 2026.
  • Highline Wealth Partners sold 22 Insulet shares in Q3 2026, an estimated $3.29K.
  • Insulet made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #1294 holding.
  • Highline Wealth Partners first reported a position in Insulet in Q1 2025 and has held it in 7 quarters since.
  • Highline Wealth Partners's Insulet position peaked at $5.02K in Q2 2026.
  • 129 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.